[Herald Interview] Despite high hurdles, Korea bent on developing drugs
HealthApr 8, 2021
When it comes to new drug development, South Korea has built strength in cancer treatment fields, but it lacks attention to infectious disease treatments, said the country’s point man on new drug development support. “The local infectious diseases pipelines account for around 9 percent of the total, compared to around 18 percent of the global drug market. The area has been less developed largely as the country has been considered as being relatively safer from infectious diseases